Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 5;62(1 Suppl 3):E6-E17.
doi: 10.15167/2421-4248/jpmh2021.62.1S3.1851. eCollection 2021 Mar.

Evaluation and review of preventive measures applied during COVID-19 pandemic: strategies adopted by European countries

[Article in Italian]
Affiliations
Review

Evaluation and review of preventive measures applied during COVID-19 pandemic: strategies adopted by European countries

[Article in Italian]
Armando Stefanati et al. J Prev Med Hyg. .

Abstract

The COVID-19 pandemic has greatly jeopardized the European continent and the spread of SARS-COV-2 has led European countries to implement a series of preventive interventions aimed at decreasing the incidence rate of the disease, in consideration of the lack of specific therapies and of a vaccine. Each European country has behaved in different ways and timing accordingly to the epidemiological trend and to different political strategies. The main purpose of preventive measures is to lower the incidence rate of the disease, avoiding the collapse of health systems and limiting the total number of severe cases and deaths. All these targets should fit with needs that go beyond scientific evidence such as economic interests, decisions of neighboring countries and specific socio-political factors for each country. The objective of this research is to clarify which preventive measures have been recommended and applied in different European countries.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement Armando Stefanati, Erica d’Anchera, Francesco De Motoli and Marta Savio declare no conflict of interest. Giovanni Gabutti declares that he does not have a specific conflict of interest related to this paper; however, he reports grants from Sanofi Pasteur MSD, GSK Biologicals SA, Pfizer, Sanofi Pasteur Italy, MSD Italy, Emergent BioSolutions and Seqirus for taking part in advisory boards, expert meetings, acting as speaker and/or organizer of meetings/congresses and acting as principal investigator and chief of OU in RCTs.

Figures

Fig. 1.
Fig. 1.
Survival time of SARS-CoV-2 on different surface. Modified from [10].
Fig. 2.
Fig. 2.
Total number of confirmed cases and “stay-at-home” orders in Italy, France, Spain, United Kingdom, Belgium, Germany, Netherlands and Sweden; March 1st - 1 July 1st 2020. The coloured area represents the period of national enforced lockdown. Modified from [31, 36-40].
Fig. 3.
Fig. 3.
Daily ICU occupancy, March, 1, 2020 - July, 1, 2020. Data from Spain relatively to this period was not available; data from Germany, Sweden, Belgium and UK are available later than March, 1 [21].
Fig. 4.
Fig. 4.
Timing of use of mask. Modified from [31, 41].

Similar articles

Cited by

References

    1. ECDC. Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – tenth update. 2020. https://www.ecdc.europa.eu/sites/default/files/documents/RRA-COVID19-upd... (accessed Jun. 15, 2020).
    1. Gabutti G, D’Anchera E, Sandri F, Savio M, Stefanati A. Coronavirus: update related to the current outbreak of COVID-19. Infect Dis Ther 2020;9:241-53. https://doi.org/10.1007/s40121-020-00295-5. 10.1007/s40121-020-00295-5 - DOI - PMC - PubMed
    1. ECDC. COVID-19 pandemic. https://www.ecdc.europa.eu/en/covid-19-pandemic (accessed Oct. 09, 2020).
    1. WHO. Coronavirus disease (COVID-19) global epidemiological situation. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... (accessed Oct. 09, 2020).
    1. Istituto Superiore di Sanità. Indicazioni ad interim per la sanificazione degli ambienti interni nel contesto sanitario e assistenziale per prevenire la trasmissione di SARS-CoV 2. Roma 2020.